The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.

Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.

Accelerate CGT developement with strategic viral vector manufacturing and CDMO partnerships that balance quality, cost, and speed from bench to clinic.

Trenchant BioSystems and Invetech agreed to collaborate on the continued development of Trenchant’s fully automated AutoCell Platform, intended for future commercialization. According to company ...

Cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) Locus Cell has signed a Memorandum of ...

Abstract: In the production process, spare parts are assembled to become products. To improve product quality and reduce cost, it is required to determine whether to detect the quality of spare parts, ...